Thrivent Financial for Lutherans’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-39,900
Closed -$2.48M 2557
2020
Q4
$2.48M Sell
39,900
-74,157
-65% -$4.54M 0.01% 1182
2020
Q3
$6.67M Buy
114,057
+434
+0.4% +$32.1K 0.02% 707
2020
Q2
$12.7M Buy
113,623
+267
+0.2% +$19K 0.04% 493
2020
Q1
$7.63M Sell
113,356
-147
-0.1% -$14.8K 0.03% 568
2019
Q4
$15.7M Buy
113,503
+10,088
+10% +$1.31M 0.04% 441
2019
Q3
$10.9M Buy
103,415
+3,372
+3% +$337K 0.03% 483
2019
Q2
$10.6M Buy
100,043
+7,924
+9% +$1.04M 0.03% 498
2019
Q1
$14.2M Buy
92,119
+372
+0.4% +$43.1K 0.04% 391
2018
Q4
$8.53M Buy
91,747
+6,265
+7% +$895K 0.03% 494
2018
Q3
$15.9M Buy
85,482
+46,757
+121% +$13.3M 0.05% 379
2018
Q2
$16.3M Buy
+38,725
New +$13.1M 0.05% 365

Other funds holding OPTN

Thrivent Financial for Lutherans's OPTN Position: Q1 2021 in Review

Thrivent Financial for Lutherans sold out of OptiNose (OPTN) in Q1 2021, closing a stake of 39,900 shares — an estimated $2.48M sold.

Thrivent Financial for Lutherans first reported a position in OPTN in Q2 2018 and held it in 11 quarters. The position peaked at $16.3M in Q2 2018. 68 funds tracked by Wall St. Rank hold OPTN as of Q1 2021.

  • Thrivent Financial for Lutherans reported no remaining OptiNose position as of Q1 2021 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 39,900 OptiNose shares in Q1 2021, an estimated $2.48M.
  • Thrivent Financial for Lutherans first reported a position in OptiNose in Q2 2018 and held it in 11 quarters.
  • Thrivent Financial for Lutherans's OptiNose position peaked at $16.3M in Q2 2018.
  • 68 funds tracked by Wall St. Rank held OptiNose as of Q1 2021.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2021, filed 17 May 2021.